Price $1.49 |
Market Cap
7.4M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
0.57
|
P/S
0.16
|
Dividend %
-
|
|
P/CF
-
|
P/FCF
-
|
Op. Cash Flow
-2.2K
|
FCF
-0.1
|
|
Op. Margin
-9.30%
|
Net Margin
-11.50%
|
ROE
-37.20%
|
ROI
-29.90%
|
|
ROA
-14.30%
|
EPS Growth
-607.10%
|
Current Ratio
1.9
|
Debt/Equity
13.90%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Vivos Inc (RDGL) | $0.06 | - | - | 24.9M | Strong Buy |
| Invo Bioscience Inc (INVO) | $0.60 | - | - | 7.4M | Strong Buy |
| Interpace Biosciences Inc (IDXG) | $1.11 | - | - | 5.1M | Strong Buy |
| IM Cannabis Corp (IMCC) | $0.74 | - | - | 13.9M | Strong Buy |
| Harvard Bioscience, Inc. (HBIO) | $4.22 | - | - | 110.4M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
